Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.5B | 1.6B | 1.5B |
Cost of revenue | 206.7M | 220.8M | 218.8M | 204.7M |
Gross profit | 1.4B | 1.3B | 1.4B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 28.5M | 33.9M | 31M | 34.7M |
Other operating expenses | 216.6M | 240.1M | 226.5M | 208.3M |
Operating income | 1.1B | 947.1M | 1.0B | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 41.7M | 40.7M | 40.2M | 40.1M |
Other income expense | 178.5M | 190.2M | 192.9M | 194M |
Pretax income | 1.2B | 1.1B | 1.2B | 1.2B |
Tax provision | 288.6M | 222M | 264.1M | 271.3M |
Net income | 956.2M | 874.6M | 912.8M | 883.2M |
Basic EPS | 2.6 | 2.4 | 2.5 | 2.4 |
Diluted EPS | 2.6 | 2.4 | 2.5 | 2.4 |
Basic average shares | 359.6M | 359.6M | 359.4M | 359.3M |
Diluted average shares | 360.2M | 360.1M | 360.0M | 359.9M |
EBITDA | 476.3M | 284.2M | 274.2M | 234.3M |
Net income from continuing op. | 956.2M | 874.6M | 912.8M | 883.2M |
Minority interests | — | — | — | — |
Preferred stock dividends | 6.3M | -21M | 6.2M | 5.8M |